0002055053-26-000003.txt : 20260812 0002055053-26-000003.hdr.sgml : 20260812 20260812172326 ACCESSION NUMBER: 0002055053-26-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260812 DATE AS OF CHANGE: 20260812 EFFECTIVENESS DATE: 20260812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BTB Therapeutics, Inc. CENTRAL INDEX KEY: 0002055053 ORGANIZATION NAME: EIN: 994821536 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-565357 FILM NUMBER: 261268861 BUSINESS ADDRESS: STREET 1: 26281 WYNDEMERE COURT CITY: ESCONDIDO STATE: CA ZIP: 92026 BUSINESS PHONE: (858) 945-3733 MAIL ADDRESS: STREET 1: 26281 WYNDEMERE COURT CITY: ESCONDIDO STATE: CA ZIP: 92026 D/A 1 primary_doc.xml X0708 D/A LIVE 0002055053 BTB Therapeutics, Inc. 26281 WYNDEMERE COURT ESCONDIDO CA CALIFORNIA 92026 (858) 945-3733 DELAWARE None None Corporation true 2024 Takashi Kiyoizumi 26281 Wyndemere Court Escondido CA CALIFORNIA 92026 Executive Officer Director Nobuhiro Yagi 26281 Wyndemere Court Escondido CA CALIFORNIA 92026 Director Masatoshi Hagiwara 26281 Wyndemere Court Escondido CA CALIFORNIA 92026 Director David Snyder 26281 Wyndemere Court Escondido CA CALIFORNIA 92026 Director Sidney Yee 26281 Wyndemere Court Escondido CA CALIFORNIA 92026 Director Pharmaceuticals Decline to Disclose 06b true 0002055053-25-000003 2025-11-14 false true false 0 10402704 8902204 1500500 false 4 0 0 250000 true false BTB Therapeutics, Inc. Takashi Kiyoizumi Takashi Kiyoizumi Chief Executive Officer 2026-08-12